Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Antibody-Dependent Cell-Mediated Cytotoxicity
8%
Antineoplastic Activity
16%
Antiparasitic Agent
8%
Avelumab
8%
Basophil
5%
Cancer Cell
20%
Cell Surface
9%
Chondroitin Sulfate Proteoglycan
49%
Cyclin E
8%
Cytotoxicity
5%
Fc Receptor
10%
Gamma Urogastrone
49%
Glycosylation
8%
Hypersensitive Response
13%
Hypersensitivity
8%
Immune Response
8%
Immunocompetent Cell
26%
Immunoglobulin E
98%
Immunoglobulin E Antibody
100%
Immunotherapy
20%
Macrophage
9%
Melanoma Antigen
24%
Programmed Death-Ligand 1
24%
Rat Model
27%
Therapeutic Antibodies
15%
Trastuzumab
24%
Tumor Antigen
6%
Tumor Cell
5%
Type I Hypersensitivity
9%
Xenograft
16%
Pharmacology, Toxicology and Pharmaceutical Science
Allergic Reaction
8%
Antiparasitic Agent
8%
Cancer Model
24%
Clinical Trial
8%
Diseases
8%
Erethism
8%
Immunoglobulin E
24%
Immunoglobulin E Antibody
24%
Immunotherapy
7%
Malignant Neoplasm
27%
Neoplasm
26%
Solid Malignant Neoplasm
8%
Triple Negative Breast Cancer
24%
Medicine and Dentistry
Cancer Cell
9%
Cancer Model
24%
Cyclin-Dependent Kinase
24%
Immunocompetent Cell
9%
Immunotherapy
7%
Neoplasm
9%
Programmed Death-Ligand 1
24%
Triple Negative Breast Cancer
24%